Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

JC Mathers, M Movahedi, F Macrae, JP Mecklin, G Moeslein, S Olschwang, D Eccles, G Evans, ER Maher, L Bertario, ML Bisgaard, M Dunlop, JWC Ho, S Hodgson, A Lindblom, J Lubinski, PJ Morrison, V Murday, R Ramesar, L SideRJ Scott, HJW Thomas, H Vasen, AM Gerdes, G Barker, G Crawford, F Elliott, K Pylvanainen, J (Juul) van Wijnen, Riccardo Fodde, H Lynch, DT Bishop, J Burn

Research output: Contribution to journalArticleAcademicpeer-review

82 Citations (Scopus)


Background Observational studies report that higher intake of dietary fibre (a heterogeneous mix including non-starch polysaccharides and resistant starches) is associated with reduced risk of colorectal cancer, but no randomised trials with prevention of colorectal cancer as a primary endpoint have been done. We assessed the effect of resistant starch on the incidence of colorectal cancer. Methods In the CAPP2 study, individuals with Lynch syndrome were randomly assigned in a two-by-two factorial design to receive 600 mg aspirin or aspirin placebo or 30 g resistant starch or starch placebo, for up to 4 years. Randomisation was done with a block size of 16. Post-intervention, patients entered into double-blind follow-up; participants and investigators were masked to treatment allocation. The primary endpoint for this analysis was development of colorectal cancer in participants ran Findings 463 patients were randomly assigned to receive resistant starch and 455 to receive resistant-starch placebo. At a median follow-up 52.7 months (IQR 28.9-78.4), 53 participants developed 61 primary colorectal cancers (27 of 463 participants randomly assigned to resistant starch, 26 of 455 participants assigned to resistant-starch placebo). Intention-to-treat analysis of time to first colorectal cancer showed a hazard ratio (HR) of 1.40 (95% CI 0.78-2.56; p=0.26) and Poisson regression ac Interpretation Resistant starch had no detectable effect on cancer development in carriers of hereditary colorectal cancer. Dietary supplementation with resistant starch does not emulate the apparently protective effect of diets rich in dietary fibre against colorectal cancer.
Original languageUndefined/Unknown
Pages (from-to)1242-1249
Number of pages8
JournalLancet Oncology
Issue number12
Publication statusPublished - 2012

Research programs

  • EMC MM-03-24-01

Cite this